Becton Dickinson & Co 1BDX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Becton Dickinson to Invest $19 Billion in U.S. in Exchange for Tariff Relief — Update
-
Becton Dickinson Inks Deal With Trump Administration to Invest $19 Billion in U.S. in Exchange for Tariff Relief
-
Becton Dickinson Resumes U.S. Shipments of ChloraPrep
-
Waters Gets FDA Approval for At-Home HPV Self-Collection Kit
Trading Information
- Previous Close Price
- €156.95
- Day Range
- €159.35–159.35
- 52-Week Range
- €122.40–176.60
- Bid/Ask
- €0.00 / €0.00
- Shares Outstanding
- 272.39M
- Market Cap
- $44.44B
- Volume/Avg
- 1 / 31
Key Statistics
- Price/Earnings (Normalized)
- 14.27
- Price/Sales
- 2.62
- Dividend Yield (Trailing)
- 2.30%
- Dividend Yield (Forward)
- 2.33%
- Dividend Payment Schedule
- Mar, Jun, Sep, Dec
- Total Yield
- 7.10%
Company Profile
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Mid Value
- Total Number of Employees
- 72,000
- Website
- https://www.bd.com
Competitors
Valuation
|
Metric
|
1BDX
|
BAX
|
MDT
|
|---|---|---|---|
Price/Earnings (Normalized) | 14.27 | 11.94 | 15.63 |
Price/Book Value | 2.03 | 2.03 | 2.25 |
Price/Sales | 2.62 | 1.09 | 3.03 |
Price/Cash Flow | 14.00 | 11.33 | 12.70 |
Price/Earnings
1BDX
BAX
MDT
Financial Strength
|
Metric
|
1BDX
|
BAX
|
MDT
|
|---|---|---|---|
Quick Ratio | 0.33 | 1.12 | 1.29 |
Current Ratio | 0.87 | 1.95 | 2.07 |
Interest Coverage | 4.15 | −0.81 | 10.12 |
Quick Ratio
1BDX
BAX
MDT
Profitability
|
Metric
|
1BDX
|
BAX
|
MDT
|
|---|---|---|---|
Return on Assets (Normalized) | 4.97% | 4.99% | 8.31% |
Return on Equity (Normalized) | 10.63% | 15.42% | 15.59% |
Return on Invested Capital (Normalized) | 7.26% | 7.44% | 10.57% |
Return on Assets
1BDX
BAX
MDT
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|RnN?!r< | LOCK|?v | $150B | |||
| Becton Dickinson & Co
BDX
| LOCK|k! | LOCK|zLjD | $50B | |||
| ResMed Inc
RMD
| LOCK|^WTY@p^ | LOCK|GtXs | $32B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|$$^<!^ | LOCK|x^s& | $32B | |||
| Alcon Inc
ALC
| LOCK|V&gmQ^d | LOCK|WkMr# | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|<Dskrx>q | LOCK|%@h | $26B | |||
| Solventum Corp
SOLV
| LOCK|W?vYD# | LOCK|VND | $15B | |||
| Baxter International Inc
BAX
| LOCK|wF | LOCK|r?FT | $13B | |||
| Repligen Corp
RGEN
| LOCK|w%qp!Qt | LOCK|>BF@T | $11B | |||
| The Cooper Companies Inc
COO
| LOCK|#R>!@bf | LOCK|ZZ?rh | $10B |
United States